5AM Venture Management, LLC Long-Term Concentrated

CIK: 0001799883 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $492,476 (100.0% shares, 0.0% debt)

Holdings (16)

VOR BIOPHARMA INC 21.3%
Value ($000) $104,937 Shares 6,692,429 Est. Cost $43.10 Unrealized
RALLYBIO CORP 15.0%
Value ($000) $73,673 Shares 4,190,724 Est. Cost $17.58 Unrealized
AKOUOS INC 9.7%
Value ($000) $48,016 Shares 4,135,784 Est. Cost $22.50 Unrealized
HOMOLOGY MEDICINES INC 7.2%
Value ($000) $35,698 Shares 4,535,919 Est. Cost $20.70 Unrealized
IDYA IDEAYA BIOSCIENCES INC 7.2%
Value ($000) $35,637 Shares 1,398,066 Est. Cost $7.13 Unrealized +227.3%
IMPEL NEUROPHARMA INC 7.1%
Value ($000) $35,137 Shares 2,884,791 Est. Cost $8.85 Unrealized
ARVN ARVINAS INC 6.7%
Value ($000) $32,872 Shares 400,000 Est. Cost $29.28 Unrealized +201.9%
CABA CABALETTA BIO INC 5.8%
Value ($000) $28,689 Shares 2,359,263 Est. Cost $11.85 Unrealized -22.2%
CRNX CRINETICS PHARMACEUTICALS IN 5.8%
Value ($000) $28,676 Shares 1,362,286 Est. Cost $19.04 Unrealized +9.9%
SCPHARMACEUTICALS INC 5.2%
Value ($000) $25,479 Shares 3,831,474 Est. Cost $5.92 Unrealized
RNAM AVIDITY BIOSCIENCES INC 2.8%
Value ($000) $13,683 Shares 555,555 Est. Cost $21.74 Unrealized 0.0%
IVERIC BIO INC 2.5%
Value ($000) $12,505 Shares 770,000 Est. Cost $16.24 Unrealized
JANX JANUX THERAPEUTICS INC 2.0%
Value ($000) $9,653 Shares 446,266 Est. Cost $22.27 Unrealized +29.2%
5 01 ACQUISITION CORP 0.7%
Value ($000) $3,586 Shares 365,126 Est. Cost $10.17 Unrealized
CIDARA THERAPEUTICS INC 0.5%
Value ($000) $2,541 Shares 1,134,511 Est. Cost $3.84 Unrealized
SPRY SILVERBACK THERAPEUTICS INC 0.3%
Value ($000) $1,694 Shares 169,748 Est. Cost $24.66 Unrealized 0.0%